382150.KQ
Oncocross Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 3,450.00
−2.68%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- 0.00x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- -0.00x
Liquidity & coverage
- Current ratio
- 1.44x
- Quick ratio
- 1.44x
- Cash ratio
- 1.35x
- Interest coverage
- -7.39x
- EBITDA / interest
- -7.90x
- Working capital
- KRW 8.1B
Cash & dividend
- FCF / debt
- -29.08x
- Cash flow / debt
- -21.80x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026